Oligonucleotides fluorescence in situ hybridization (Oligo-FISH) is an rising know-how and is a crucial device in analysis areas comparable to detection of chromosome variation, identification of allopolyploid, and deciphering of three-dimensional (3D) genome constructions. Primarily based on the demand for extremely environment friendly oligo probes for oligo-FISH experiments, growing numbers of instruments have been developed for probe design lately. Out of date oligonucleotide design instruments have been tailored for oligo-FISH probe design due to their comparable issues.
With the event of DNA sequencing and large-scale synthesis, novel instruments have been designed to extend the specificity of designed oligo probes and allow genome-scale oligo probe design, which has tremendously improved the appliance of single copy oligo-FISH. Regardless of this, few research have launched the event of the oligo-FISH probe design instruments and their utility in FISH experiments systematically. Apart from, a complete comparability and analysis is missing for the out there instruments. On this evaluation, we offer an outline of the oligo-FISH probe design course of, summarize the event and utility of the out there instruments, consider a number of state-of-art instruments, and finally present steering for single copy oligo-FISH probe design.
At the moment there’s an pressing must develop antiviral medicine and alleviate present COVID-19 pandemic. Though many candidates have been developed, we right here designed and constructed chimeric oligonucleotides comprising a 2′-OMe modified antisense oligonucleotide and a 5′-phosphorylated 2′-5′ poly(A) 4 (4A 2-5 ) to degrade envelope and spike RNAs of SARS-CoV-2. The oligonucleotide was used for looking and recognizing goal viral RNA sequence, and the conjugated 4A 2-5 was used for guided ribonuclease L (RNase L) activation to sequence-specifically degrade viral RNAs.
Since RNase L can potently cleave single strand RNA throughout innate antiviral response, degradation efficiencies with these chimeras have been twice as a lot as solely 2′-OMe modified oligonucleotides for each SARS-CoV-2 RNA targets. In pseudovirus an infection fashions, one of many chimeras concentrating on spike RNA achieved potent and broad-spectrum inhibition of SARS-CoV-2 and its N501Y and/or ΔH69/ΔV70 mutants.
Simultaneous quantitation of inorganic ions in oligonucleotides utilizing mixed-mode liquid chromatography coupled with a charged aerosol detector
The quantities of inorganic ions (e.g. sodium, potassium, magnesium, calcium, chloride, and phosphate) in intrathecally administered oligonucleotide drug merchandise should be managed with a view to meet the ultimate goal formulation composition. Throughout course of growth, these ions are measured to make sure the answer composition doesn’t change throughout purification or drug product compounding and to make sure the ultimate drug product targets are achieved.
A quantitative methodology for ion evaluation in antisense oligonucleotide (ASO) medicine was developed by mixed-mode anion trade/cation exchange-hydrophilic interplay liquid chromatography (AEX/CEX-HILIC) with a charged aerosol detector (CAD). This thirteen-minute methodology measures monovalent and multivalent cations and anions concurrently. LC separation circumstances, CAD parameters, and pattern preparation have been judiciously optimized to make sure that the strategy is restricted, correct, exact, linear, strong, and rugged. With this LC-CAD method, ion evaluation for oligonucleotide medicine may be carried out in most analytical labs to help drug growth.
Antisense Oligonucleotide-Mediated Discount of HDAC6 Does Not Scale back Tau Pathology in P301S Tau Transgenic Mice
Acetylation of tau protein is dysregulated in Alzheimer’s Illness (AD). It has been proposed that acetylation of particular websites within the KXGS motif of tau can regulate phosphorylation of close by residues and scale back the propensity of tau to mixture. Histone deacetylase 6 (HDAC6) is a cytoplasmic enzyme concerned in deacetylation of a number of targets, together with tau, and it has been steered that inhibition of HDAC6 would enhance tau acetylation on the KXGS motifs and thus might current a viable therapeutic method to deal with AD.
To instantly take a look at the contribution of HDAC6 to tau pathology, we intracerebroventricularly injected an antisense oligonucleotide (ASO) directed towards HDAC6 mRNA into brains of P301S tau mice (PS19 mannequin), which resulted in a 70% knockdown of HDAC6 protein within the mind. Regardless of a sturdy lower in ranges of HDAC6, no enhance in tau acetylation was noticed. Moreover, no change of tau phosphorylation or tau aggregation was detected upon the knockdown of HDAC6. We conclude that HDAC6 doesn’t affect tau pathology in PS19 mice.
Efficient silencing of miR-126 after ischemic stroke via intravenous α-tocopherol-conjugated heteroduplex oligonucleotide in mice
Mind endothelial cells (BECs) are concerned within the pathogenesis of ischemic stroke. Lately, a number of microRNAs (miRNAs) in BECs have been reported to manage the endothelial operate in ischemic mind. Due to this fact, modulation of miRNAs in BECs by a therapeutic oligonucleotide to inhibit miRNA (antimiR) might be a helpful technique for treating ischemic stroke. Nevertheless, few makes an attempt have been made to realize this technique through systemic route because of lack of environment friendly delivery-method towards BECs.
Right here, we have now developed a brand new know-how for delivering an antimiR into BECs and silencing miRNAs in BECs, utilizing a mouse ischemic stroke mannequin. We designed a heteroduplex oligonucleotide, comprising an antimiR towards miRNA-126 (miR-126) often called the endothelial-specific miRNA and its complementary RNA, conjugated to α-tocopherol as a supply ligand (Toc-HDO concentrating on miR-126). Intravenous administration of Toc-HDO concentrating on miR-126 remarkably suppressed miR-126 expression in ischemic mind of the mannequin mice.
Family with Sequence Similarity 129, Member B (FAM129B) Antibody |
|||
| abx331409-100ul | Abbexa | 100 ul | EUR 510 |
Human Protein FAM129B (FAM129B) ELISA Kit |
|||
| abx387257-96tests | Abbexa | 96 tests | EUR 1093.2 |
FAM129B siRNA |
|||
| 20-abx916030 | Abbexa |
|
|
FAM129B siRNA |
|||
| 20-abx916031 | Abbexa |
|
|
FAM129B siRNA |
|||
| 20-abx901842 | Abbexa |
|
|
anti- FAM160B1 antibody |
|||
| FNab02970 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against FAM160B1 |
|||
anti- FAM160B2 antibody |
|||
| FNab02971 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against FAM160B2 |
|||
anti- FAM111B antibody |
|||
| FNab02954 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against FAM111B |
|||
anti- FAM116B antibody |
|||
| FNab02956 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against FAM116B |
|||
anti- FAM117B antibody |
|||
| FNab02957 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against FAM117B |
|||
anti- FAM118B antibody |
|||
| FNab02958 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against FAM118B |
|||
anti- FAM124B antibody |
|||
| FNab02961 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against FAM124B |
|||
anti- FAM127B antibody |
|||
| FNab02963 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against FAM127B |
|||
anti- FAM168B antibody |
|||
| FNab02973 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against FAM168B |
|||
anti- FAM186B antibody |
|||
| FNab02976 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against FAM186B |
|||
anti- FAM40B antibody |
|||
| FNab02984 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against FAM40B |
|||
anti- FAM46B antibody |
|||
| FNab02985 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against FAM46B |
|||
anti- FAM49B antibody |
|||
| FNab02987 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against FAM49B |
|||
anti- FAM57B antibody |
|||
| FNab02989 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against FAM57B |
|||
anti- FAM65B antibody |
|||
| FNab02991 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against FAM65B |
|||
anti- FAM84B antibody |
|||
| FNab02997 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against FAM84B |
|||
anti- FAM96B antibody |
|||
| FNab03000 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against FAM96B |
|||
anti- FAM98B antibody |
|||
| FNab03001 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against FAM98B |
|||
FAM129B ELISA KIT|Human |
|||
| EF009517 | Lifescience Market | 96 Tests | EUR 826.8 |
Rat FAM129B shRNA Plasmid |
|||
| 20-abx990325 | Abbexa |
|
|
Mouse FAM129B shRNA Plasmid |
|||
| 20-abx981593 | Abbexa |
|
|
Human FAM129B shRNA Plasmid |
|||
| 20-abx962121 | Abbexa |
|
|
FAM129B Recombinant Protein (Rat) |
|||
| RP200402 | ABM | 100 ug | Ask for price |
FAM129B Recombinant Protein (Mouse) |
|||
| RP132935 | ABM | 100 ug | Ask for price |
FAM129B Recombinant Protein (Human) |
|||
| RP057474 | ABM | 100 ug | Ask for price |
Fam129b ORF Vector (Rat) (pORF) |
|||
| ORF066802 | ABM | 1.0 ug DNA | EUR 607.2 |
Fam129b ORF Vector (Mouse) (pORF) |
|||
| ORF044313 | ABM | 1.0 ug DNA | EUR 607.2 |
FAM129B ORF Vector (Human) (pORF) |
|||
| ORF019159 | ABM | 1.0 ug DNA | EUR 486 |
Anti-FAM129B antibody |
|||
| PAab02965 | Lifescience Market | 100 ug | EUR 463.2 |
Fam129b sgRNA CRISPR Lentivector set (Rat) |
|||
| K6504001 | ABM | 3 x 1.0 ug | EUR 406.8 |
Fam129b sgRNA CRISPR Lentivector set (Mouse) |
|||
| K4870701 | ABM | 3 x 1.0 ug | EUR 406.8 |
FAM129B sgRNA CRISPR Lentivector set (Human) |
|||
| K0745701 | ABM | 3 x 1.0 ug | EUR 406.8 |
Fam129b 3'UTR GFP Stable Cell Line |
|||
| TU156140 | ABM | 1.0 ml | Ask for price |
FAM129B 3'UTR GFP Stable Cell Line |
|||
| TU057555 | ABM | 1.0 ml | EUR 1825.2 |
Fam129b 3'UTR GFP Stable Cell Line |
|||
| TU254268 | ABM | 1.0 ml | Ask for price |
FAM129B Protein Vector (Rat) (pPM-C-HA) |
|||
| PV267208 | ABM | 500 ng | EUR 1399.2 |
FAM129B Protein Vector (Rat) (pPB-C-His) |
|||
| PV267206 | ABM | 500 ng | EUR 1399.2 |
FAM129B Protein Vector (Rat) (pPB-N-His) |
|||
| PV267207 | ABM | 500 ng | EUR 1399.2 |
FAM129B Protein Vector (Rat) (pPM-C-His) |
|||
| PV267209 | ABM | 500 ng | EUR 1399.2 |
FAM129B Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV177252 | ABM | 500 ng | EUR 1278 |
FAM129B Protein Vector (Human) (pPM-C-HA) |
|||
| PV076635 | ABM | 500 ng | EUR 662.4 |
FAM129B Protein Vector (Mouse) (pPB-C-His) |
|||
| PV177250 | ABM | 500 ng | EUR 1278 |
FAM129B Protein Vector (Mouse) (pPB-N-His) |
|||
| PV177251 | ABM | 500 ng | EUR 1278 |
FAM129B Protein Vector (Mouse) (pPM-C-His) |
|||
| PV177253 | ABM | 500 ng | EUR 1278 |
FAM129B Protein Vector (Human) (pPB-C-His) |
|||
| PV076633 | ABM | 500 ng | EUR 662.4 |
FAM129B Protein Vector (Human) (pPB-N-His) |
|||
| PV076634 | ABM | 500 ng | EUR 662.4 |
FAM129B Protein Vector (Human) (pPM-C-His) |
|||
| PV076636 | ABM | 500 ng | EUR 662.4 |
FAM129B 3'UTR Luciferase Stable Cell Line |
|||
| TU007555 | ABM | 1.0 ml | EUR 1825.2 |
Fam129b 3'UTR Luciferase Stable Cell Line |
|||
| TU106140 | ABM | 1.0 ml | Ask for price |
Fam129b 3'UTR Luciferase Stable Cell Line |
|||
| TU204268 | ABM | 1.0 ml | Ask for price |
Fam129b sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K6504002 | ABM | 1.0 ug DNA | EUR 184.8 |
Fam129b sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K6504003 | ABM | 1.0 ug DNA | EUR 184.8 |
Fam129b sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K6504004 | ABM | 1.0 ug DNA | EUR 184.8 |
Fam129b sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K4870702 | ABM | 1.0 ug DNA | EUR 184.8 |
Fam129b sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K4870703 | ABM | 1.0 ug DNA | EUR 184.8 |
Fam129b sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K4870704 | ABM | 1.0 ug DNA | EUR 184.8 |
FAM129B sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K0745702 | ABM | 1.0 ug DNA | EUR 184.8 |
FAM129B sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K0745703 | ABM | 1.0 ug DNA | EUR 184.8 |
FAM129B sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K0745704 | ABM | 1.0 ug DNA | EUR 184.8 |
FAM160B2 antibody |
|||
| 38631-100ul | SAB | 100ul | EUR 302.4 |
FAM160B2 antibody |
|||
| 70R-17214 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal FAM160B2 antibody |
|||
FAM108B1 antibody |
|||
| 70R-3168 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal FAM108B1 antibody raised against the middle region of FAM108B1 |
|||
FAM160B1 antibody |
|||
| 70R-4079 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal FAM160B1 antibody raised against the N terminal of FAM160B1 |
|||
FAM160B2 Antibody |
|||
| ABD7245 | Lifescience Market | 100 ug | EUR 525.6 |
FAM160B2 Antibody |
|||
| DF7245 | Affbiotech | 200ul | EUR 420 |
FAM149B1 Antibody |
|||
| 1-CSB-PA839295LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM149B1. Recognizes FAM149B1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200 |
|||
FAM160B2 Antibody |
|||
| 1-CSB-PA008108GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM160B2. Recognizes FAM160B2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
|||
FAM160B1 Antibody |
|||
| 1-CSB-PA726129LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM160B1. Recognizes FAM160B1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
FAM193B Antibody |
|||
| 6941-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: FAM193B Antibody: FAM193B, also known as IRIZIO, was initially identified as a protein that is upregulated in alveolar rhabdomyosarcoma (ARMS), a type of fast-growing tumor characterized by chromosomal translocations fusing the PAX3 or PAX7 gene with that of FOXO1. It has been suggested that, in addition to the PAX3-FOXO1 gene fusion, disruption of the Rb and p53 pathways is required for full ARMS tumorigenesis. In PAX3-FOXO1-expressing primary mouse fibroblasts that possessed a defective p53 pathway, FAM193B expression enabled the tumorigenic transformation, suggesting that FAM193B may contribute to rhabdomyosarcomagenesis in humans. |
|||
FAM193B Antibody |
|||
| 6941-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: FAM193B Antibody: FAM193B, also known as IRIZIO, was initially identified as a protein that is upregulated in alveolar rhabdomyosarcoma (ARMS), a type of fast-growing tumor characterized by chromosomal translocations fusing the PAX3 or PAX7 gene with that of FOXO1. It has been suggested that, in addition to the PAX3-FOXO1 gene fusion, disruption of the Rb and p53 pathways is required for full ARMS tumorigenesis. In PAX3-FOXO1-expressing primary mouse fibroblasts that possessed a defective p53 pathway, FAM193B expression enabled the tumorigenic transformation, suggesting that FAM193B may contribute to rhabdomyosarcomagenesis in humans. |
|||
FAM111B antibody |
|||
| 70R-17204 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal FAM111B antibody |
|||
FAM117B antibody |
|||
| 70R-17205 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal FAM117B antibody |
|||
FAM118B antibody |
|||
| 70R-17206 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal FAM118B antibody |
|||
FAM124B antibody |
|||
| 70R-17209 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal FAM124B antibody |
|||
FAM127B antibody |
|||
| 70R-17211 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal FAM127B antibody |
|||
FAM122B antibody |
|||
| 70R-13027 | Fitzgerald | 100 ul | EUR 548.4 |
|
Description: Affinity purified Rabbit polyclonal FAM122B antibody |
|||
FAM121B antibody |
|||
| 70R-1479 | Fitzgerald | 100 ug | EUR 452.4 |
|
Description: Rabbit polyclonal FAM121B antibody raised against the C terminal Of Fam121B |
|||
FAM121B antibody |
|||
| 70R-1480 | Fitzgerald | 100 ug | EUR 452.4 |
|
Description: Rabbit polyclonal FAM121B antibody raised against the N terminal Of Fam121B |
|||
FAM134B antibody |
|||
| 70R-1786 | Fitzgerald | 100 ug | EUR 452.4 |
|
Description: Rabbit polyclonal FAM134B antibody raised against the middle region of Fam134B |
|||
FAM134B antibody |
|||
| 70R-6834 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal FAM134B antibody raised against the middle region of FAM134B |
|||
FAM135B antibody |
|||
| 70R-3897 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal FAM135B antibody raised against the middle region of FAM135B |
|||
FAM110B Antibody |
|||
| 46561-100ul | SAB | 100ul | EUR 302.4 |
FAM213B Antibody |
|||
| 46564-100ul | SAB | 100ul | EUR 302.4 |
FAM186B Antibody |
|||
| 47320-100ul | SAB | 100ul | EUR 302.4 |
FAM107B Antibody |
|||
| 47434-100ul | SAB | 100ul | EUR 302.4 |
FAM111B Antibody |
|||
| 47538-100ul | SAB | 100ul | EUR 302.4 |
FAM155B Antibody |
|||
| 47540-100ul | SAB | 100ul | EUR 302.4 |
FAM177B Antibody |
|||
| 47541-100ul | SAB | 100ul | EUR 302.4 |
FAM124B Antibody |
|||
| DF12996 | Affbiotech | 200ul | EUR 420 |
FAM134B Antibody |
|||
| DF12997 | Affbiotech | 200ul | EUR 420 |
FAM161B Antibody |
|||
| DF15997 | Affbiotech | 100ul | EUR 420 |
FAM122B Antibody |
|||
| DF16121 | Affbiotech | 100ul | EUR 420 |
FAM159B Antibody |
|||
| DF15096 | Affbiotech | 100ul | EUR 420 |
FAM162B Antibody |
|||
| DF15171 | Affbiotech | 100ul | EUR 420 |
FAM107B Antibody |
|||
| DF15200 | Affbiotech | 100ul | EUR 420 |
FAM210B Antibody |
|||
| DF15302 | Affbiotech | 100ul | EUR 420 |
FAM117B Antibody |
|||
| CSB-PA149020- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against FAM117B. Recognizes FAM117B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
|||
FAM117B Antibody |
|||
| CSB-PA149020-100ul | Cusabio | 100ul | EUR 379.2 |
|
Description: A polyclonal antibody against FAM117B. Recognizes FAM117B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
|||
FAM126B Antibody |
|||
| 1-CSB-PA814227LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM126B. Recognizes FAM126B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200 |
|||
FAM127B Antibody |
|||
| 1-CSB-PA871589LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM127B. Recognizes FAM127B from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
FAM134B Antibody |
|||
| 1-CSB-PA875683LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM134B. Recognizes FAM134B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
FAM222B Antibody |
|||
| 1-CSB-PA851963LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM222B. Recognizes FAM222B from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200 |
|||
FAM118B Antibody |
|||
| 1-CSB-PA858411LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM118B. Recognizes FAM118B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200 |
|||
FAM124B Antibody |
|||
| 1-CSB-PA880982LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM124B. Recognizes FAM124B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200 |
|||
FAM107B Antibody |
|||
| 1-CSB-PA884429LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM107B. Recognizes FAM107B from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:500-1:2000 |
|||
FAM168B Antibody |
|||
| 1-CSB-PA008125LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM168B. Recognizes FAM168B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
|||
FAM110B Antibody |
|||
| 1-CSB-PA008005LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM110B. Recognizes FAM110B from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200 |
|||
FAM111B Antibody |
|||
| 1-CSB-PA008008GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM111B. Recognizes FAM111B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
FAM117B Antibody |
|||
| 1-CSB-PA008019GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM117B. Recognizes FAM117B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF |
|||
FAM118B Antibody |
|||
| 1-CSB-PA008021GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM118B. Recognizes FAM118B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
|||
FAM124B Antibody |
|||
| 1-CSB-PA008039GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM124B. Recognizes FAM124B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
FAM127B Antibody |
|||
| 1-CSB-PA008045GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM127B. Recognizes FAM127B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
|||
FAM187B Antibody |
|||
| 1-CSB-PA623168LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM187B. Recognizes FAM187B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
FAM135B Antibody |
|||
| 1-CSB-PA677719LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM135B. Recognizes FAM135B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
FAM102B Antibody |
|||
| 1-CSB-PA735976LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM102B. Recognizes FAM102B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
|||
FAM151B Antibody |
|||
| 1-CSB-PA740923LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM151B. Recognizes FAM151B from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IF:1:50-1:200 |
|||
FAM109B Antibody |
|||
| 1-CSB-PA753688LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM109B. Recognizes FAM109B from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
FAM117B Antibody |
|||
| 1-CSB-PA754170LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM117B. Recognizes FAM117B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
FAM171B Antibody |
|||
| 1-CSB-PA757601LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM171B. Recognizes FAM171B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
|||
FAM122B Antibody |
|||
| 1-CSB-PA768758LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM122B. Recognizes FAM122B from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200 |
|||
FAM131B Antibody |
|||
| 1-CSB-PA774828LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM131B. Recognizes FAM131B from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
FAM111B Antibody |
|||
| 1-CSB-PA011307 | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM111B. Recognizes FAM111B from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/5000 |
|||
FAM117B Antibody |
|||
| 1-CSB-PA007427 | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM117B. Recognizes FAM117B from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/5000 |
|||
FAM234B Antibody |
|||
| 1-CSB-PA012262LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against FAM234B. Recognizes FAM234B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IF:1:50-1:200 |
|||
FAM159B Antibody |
|||
| F53984-0.05ML | NSJ Bioreagents | 0.05 ml | EUR 140.25 |
|
Description: Additional name(s): Family with sequence similarity 159 member B |
|||
FAM159B Antibody |
|||
| F53984-0.2ML | NSJ Bioreagents | 0.2 ml | EUR 322.15 |
|
Description: Additional name(s): Family with sequence similarity 159 member B |
|||
Mouse Niban- like protein 1, Fam129b ELISA KIT |
|||
| ELI-35343m | Lifescience Market | 96 Tests | EUR 1038 |
Human Niban- like protein 1, FAM129B ELISA KIT |
|||
| ELI-13124h | Lifescience Market | 96 Tests | EUR 988.8 |
FAM82B Antibody |
|||
| abx146070-100ug | Abbexa | 100 ug | EUR 469.2 |
FAM69B Antibody |
|||
| abx146099-100ug | Abbexa | 100 ug | EUR 469.2 |
FAM71B Antibody |
|||
| abx146112-100ug | Abbexa | 100 ug | EUR 469.2 |
FAM84B antibody |
|||
| 10R-4059 | Fitzgerald | 100 ul | EUR 871.2 |
|
Description: Mouse monoclonal FAM84B antibody |
|||
FAM84B antibody |
|||
| 10R-4060 | Fitzgerald | 100 ul | EUR 829.2 |
|
Description: Mouse monoclonal FAM84B antibody |
|||
FAM84B antibody |
|||
| 10R-4061 | Fitzgerald | 100 ul | EUR 829.2 |
|
Description: Mouse monoclonal FAM84B antibody |
|||
FAM84B antibody |
|||
| 10R-4062 | Fitzgerald | 100 ul | EUR 829.2 |
|
Description: Mouse monoclonal FAM84B antibody |
|||
FAM84B antibody |
|||
| 10R-4063 | Fitzgerald | 100 ul | EUR 829.2 |
|
Description: Mouse monoclonal FAM84B antibody |
|||
FAM84B antibody |
|||
| 10R-4064 | Fitzgerald | 100 ul | EUR 829.2 |
|
Description: Mouse monoclonal FAM84B antibody |
|||
FAM84B antibody |
|||
| 10R-4065 | Fitzgerald | 100 ul | EUR 829.2 |
|
Description: Mouse monoclonal FAM84B antibody |
|||
FAM84B antibody |
|||
| 10R-4066 | Fitzgerald | 100 ul | EUR 829.2 |
|
Description: Mouse monoclonal FAM84B antibody |
|||
As well as, we confirmed that Toc-HDO concentrating on miR-126 was delivered into BECs extra effectively than the guardian antimiR in ischemic mind, and that it was delivered extra successfully in ischemic mind than non-ischemic mind of this mannequin mice. Our research highlights the potential of this know-how as a brand new medical therapeutic possibility for ischemic stroke.